Cargando…
The CCND1 870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
A number of specific chromosomal abnormalities define the subgroups of multiple myeloma. In a meta-analysis of two genomewide association studies of multiple myeloma totaling 1,661 patients we investigated risk for developing a specific tumor karyotype. The t(11;14) (q13;q32) translocation in which...
Autores principales: | Weinhold, Niels, Johnson, David C, Chubb, Daniel, Chen, Bowang, Försti, Asta, Hosking, Fay J, Broderick, Peter, Ma, Yussanne P, Dobbins, Sara E, Hose, Dirk, Walker, Brian A, Davies, Faith E, Kaiser, Martin F, Li, Ni L, Gregory, Walter A, Jackson, Graham H, Witzens-Harig, Mathias, Neben, Kai, Hoffmann, Per, Nöthen, Markus M, Mühleisen, Thomas W, Eisele, Lewin, Ross, Fiona M, Jauch, Anna, Goldschmidt, Hartmut, Houlston, Richard S, Morgan, Gareth J, Hemminki, Kari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056630/ https://www.ncbi.nlm.nih.gov/pubmed/23502783 http://dx.doi.org/10.1038/ng.2583 |
Ejemplares similares
-
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk
por: Chubb, Daniel, et al.
Publicado: (2013) -
The t(11;14)(q13;q32)/CCND1–IGH translocation in chronic lymphocytic leukaemia/small lymphocytic lymphoma: an unusual genetic aberration during the natural clinical course
por: Liu, Ying, et al.
Publicado: (2019) -
Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
por: Broderick, Peter, et al.
Publicado: (2011) -
Is t(11;14)(q13;q32) good or bad for newly diagnosed multiple myeloma?
por: Liu, Yang, et al.
Publicado: (2023) -
Single Nucleotide Polymorphism (A870G) of the CCND1 gene: association with colorectal cancer susceptibility
por: Montazer Haghighi, Mahdi, et al.
Publicado: (2017)